跳到正文
MBC Advocate· @MBCadvocate · X·· 2026-04-21评分60

AVA6103

正文 · 原文

Best news ever! AVA6103 includes ER+ metastatic breast cancer! A major step forward!
Thank you to Team Avacta, patients, advocates, and investors for making this expansion possible. You’re the best! #AVCT #AACR26

88 赞 · 11 转发 · 2 回复

会议摘要
5846按 代号 AVA6103 对上

AVA6103 is a FAP-enabled pre|CISION®peptide-drug conjugate delivering sustained release of exatecan in the tumor microenvironment with potent antitumor activity

Curtis Rink, Tom Clough, Ellen Watts, Folake Orafidiya, Marine Houée, Sophie Brown, Victoria Juskaite, Gezim Lahu, Ruairidh Edwards, Karen Campbell, Dave Liebowitz, David Jones, Francis Wilson, Michelle Morrow

来源:MBC Advocate · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org